To confirm the co-amplification of ERBB2 and NFIB overexpression and to support the clinicopathological significance of this co-amplification in breast carcinogenesis, we collected a panel of breast cancer cell lines for western blotting analysis of the expression of NFIB. This evidence concerns the gene ERBB2 and breast carcinoma.